Business Update

U.S. Genomics, Northrop Grumman sign pact to develop biodetection sensors for U.S. defense

Published in Bioterrorism Week, January 15th, 2007

U.S. Genomics Inc. and the Northrop Grumman Corporation (NOC) have signed a agreement to work together to commercialize U.S. Genomics' single molecule detection technology.

Under the terms of the agreement, U.S. Genomics will work with Northrop Grumman Security Systems LLC to complete the development of its technology and secure contracts for its deployment to meet biodetection needs for the U.S. Department of Homeland Security and related biological detection applications.

U.S. Genomics has been awarded phase 1 and 2 contracts by the U.S. Department of Homeland Security Advanced Research Projects Agency (HSARPA) for the development of a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Bioterrorism Week

Source: Bioterrorism Week (2007-01-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry